Testimony: A Health Impact Assessment on Legalization of Medical Marijuana in Kansas (HB 2282)

1 Min Read

Feb 17, 2015

By

Tatiana Y. Lin, M.A.
Tatiana Lin, KHI Senior Analyst and Stretegy Team Leader  presented neutral testimony on Feb. 17, 2015 to the Health and Human Services Committee on HB 2282.
Tatiana Lin, KHI Senior Analyst and Stretegy Team Leader  presented neutral testimony on Feb. 17, 2015 to the Health and Human Services Committee on HB 2282.

Access this publication in the Documents & Downloads section.

KHI’ Tatiana Y. Lin, M.A., Senior Analyst and Strategy Team Leader presented neutral testimony before the House Committee on Health and Human Services on House Bill 2282 “Otis’s Law” which aims to legalize cannabis oil for seizure-related conditions. During the testimony, KHI provided a summary of similar “restrictive laws” passed by 11 states in 2014. New HIA findings were shared that related to potential health effects of medical marijuana legalization on driving under the influence, traffic accidents and accidental ingestion.

KHI researchers have developed a pathway diagram that examines multiple factors that may positively or negatively affect the health of Kansans. Additional findings and recommendations will be released next month.

Access this publication in the Documents & Downloads section.

About Kansas Health Institute

The Kansas Health Institute supports effective policymaking through nonpartisan research, education and engagement. KHI believes evidence-based information, objective analysis and civil dialogue enable policy leaders to be champions for a healthier Kansas. Established in 1995 with a multiyear grant from the Kansas Health Foundation, KHI is a nonprofit, nonpartisan educational organization based in Topeka.

Learn More About KHI